Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation
NCT ID: NCT02802176
Last Updated: 2023-07-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
39 participants
INTERVENTIONAL
2016-10-31
2022-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation
NCT02363426
3 Year Retrospective Analysis of IVF in Comparison With INVOcell
NCT05189405
Protocols for Improved in Vitro Fertilization (IVF) Outcomes
NCT00334243
Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer
NCT02024880
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
NCT03522350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary aim is implantation rate, which is defined by number gestational sacs seen on early pregnancy ultrasound divided by number of embryos transferred.
Secondary aims are:
* Embryo quality, which is measured by system similar to the Gardner grading system at cleavage stage. Reported quality will be converted to the simplified SART embryo scoring system which provides an overall categorical embryo grade of "Good", "Fair" or "Poor".
* Fertilization rate, which is defined by the total number of fertilized oocytes divided by total number of mature oocytes retrieved. This comparison will take place on day-3, as that is when the IVC embryos will be assessed.
* Clinical pregnancy rate, which is defined by the number of fetal poles with heartbeat seen on ultrasound divided by the number of embryos transferred.
* Live birth rate, which is defined by the number of living babies delivered divided by the number of transfers
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intra-vaginal culture - INVOcell device
3 day intra-vaginal incubation using the INVOcell device
INVOcell device
intra-vaginal culture of embryos using INVOcell device
Traditional IVF culture
3 day traditional IVF incubation
Traditional IVF
traditional culture of embryos in-vitro
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
INVOcell device
intra-vaginal culture of embryos using INVOcell device
Traditional IVF
traditional culture of embryos in-vitro
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* One or more years of infertility
* Normal male partner semen analysis
Exclusion Criteria
* Antral Follicle Count (AFC) \<8
* Abnormal male partner semen analysis or use of donor sperm
* Vaginal inflammation or genital (vaginal, uterine, tubal) infection
* Uncontrolled chronic disease (such as uncontrolled diabetes or hypertension)
* Uterine anatomic abnormalities
* Allergy to plastics or inability to use diaphragm retention device
* Untreated hydrosalpinx
* Current alcohol abuse (defined by \>14 drinks/week)
* Prior history of IVF cycle where fertilization did not occur
* History of recurrent pregnancy loss
18 Years
37 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelle Cedars, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Francisco - Center for Reproductive Health
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
INVOcell device
University of California San Francisco Center for Reproductive Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 166094
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.